|
|
|
| US Biostimulants Summit 2026 |
|
|
|
|
US Biostimulants Summit 2026 |
117 days left
|
| Biologicals in Practice: Evidence, Regulation and Market Impact |
| Dates:
Wednesday, August 5, 2026 - Thursday, August 6, 2026
|
| Venue: Raleigh,
Raleigh NC,
United States |
|
|
ACI's US Biostimulants Summit 2026 will take place on 05-06 August in Raleigh, North Carolina, and examines how biological products move from scientific validation to commercial use across United States agriculture. As the sector continues to expand, the discussion is increasingly shifting away from early product claims toward a more practical question: how biological inputs are evaluated, regulated and adopted within real crop systems. The conference brings together biostimulant producers, fertiliser manufacturers, distributors, advisers, researchers and regulatory stakeholders to examine the factors shaping the next phase of development for the sector.
The programme is structured around the operational and commercial realities that influence whether biological products move beyond trials into broader acreage adoption. Discussions will consider how companies approach distribution and collaboration, how market access is influenced by retail agronomy and access-to-acres constraints, and how commercial strategies are evolving as the category attracts greater capital and industry attention. Rather than revisiting introductory explanations of biological mechanisms, the agenda is designed to focus on the practical conditions under which products are assessed and implemented in the field.
A number of sessions will also examine the evidence frameworks that underpin credibility in the category. These discussions look at how field trials are designed and interpreted, how analytical techniques support product quantification and transparency, and how laboratory validation relates to performance claims made within commercial crop programmes. The conference will also explore how regulators, laboratories and industry bodies are approaching questions of testing standards, product characterisation and documentation requirements.
Alongside these themes, the event considers how evolving regulatory structures and market expectations are shaping the environment in which biological products are developed and sold. Sessions examine the interaction between federal guidance and state-level registration systems, the role of industry standards organisations, and the broader effort to improve alignment across regulatory frameworks affecting the sector.
Across two days of discussion and networking in Raleigh, the US Biostimulants Summit 2026 provides a forum for companies, researchers and agronomy professionals to exchange perspectives on how biological inputs are being evaluated, positioned and implemented within modern crop production systems. The event is intended to support informed discussion around the evidence, regulatory context and commercial conditions influencing the development of the biostimulants market in the United States.
|
Website: https://www.wplgroup.com/aci/event/biostimulants-us/
|
|
|
|
|
